Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:
A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Macquarie is bullish on a supermarket giant, citing successful market share expansion and strong sales growth, leading to an outperform rating and increased price target.
  • A biotech leader is seen as undervalued by Morgans, which maintains a buy rating despite a recent guidance downgrade, highlighting a buying opportunity due to low earnings multiples.
  • Macquarie's positive view on a buy now pay later provider is driven by its rapid growth and potential in the US market, resulting in a new coverage with a favorable price target.

It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

Coles Group Ltd (ASX: COL)

According to a note out of the Macquarie equities desk, its analysts have retained their outperform rating on this supermarket giant's shares with an improved price target of $26.10. The broker was pleased with Coles' first quarter update and notes that its sales growth outperformed its main rival. This suggests that its market share gains have continued. And with Coles appearing to be retaining its new shoppers, Macquarie believe it is well-placed to deliver strong earnings growth in the next three years. As a result, it thinks its shares are good value at current levels. The Coles share price ended the week at $22.05.

CSL Ltd (ASX: CSL)

A note out of Morgans reveals that its analysts have retained their buy rating on this biotech giant's shares with a reduced price target of $249.51. Although the broker concedes that CSL's guidance downgrade was disappointing and it remains unclear when US influenza vaccination rates will stabilise, it thinks the share price selldown has been severely overdone. As a result, Morgans believes that its shares are trading on unjustifiably low earnings multiples at present and is recommending investors buy the dip. The CSL share price was fetching $178.50 at Friday's close.

Zip Co Ltd (ASX: ZIP)

Another note out of Macquarie reveals that its analysts have initiated coverage on this buy now pay later provider's shares with a $4.85 price target. According to the note, the broker believes that Zip is an attractive investment option for Aussie investors thanks partly to its US segment. It highlights that this side of the business is currently outpacing peers. And despite US total transaction value (TTV) growing >40% annually, it still has a significant opportunity to acquire new customers in an underserved market. In light of this, it is forecasting Zip to continue to deliver rapid growth in the coming years. This will be supported by increased product adoption, expansion of merchant network, increased customer engagement, and digital product innovation. The Zip share price ended the week at $3.87.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man sitting at his dining table looks at his laptop and ponders the CSL balance sheet and the value of CSL shares today
Broker Notes

Buy, hold, sell: Flight Centre, Suncorp, and Zip shares

Let's see if analysts are bullish or bearish (or something in between).

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Does Macquarie rate Treasury Wine shares a buy the dip opportunity?

Let's see if the broker is bullish, bearish, or something in between.

Read more »

A young female ASX investor sits at her desk with her fists raised in excitement as she reads about rising ASX share prices on her laptop.
Broker Notes

Two ASX 200 stocks with buy recommendations from Ord Minnett

These two stocks appear to have strong upside.

Read more »

Person pointing finger on on an increasing graph which represents a rising share price.
Broker Notes

Experts rate these 2 ASX growth shares as buys this month!

These businesses could deliver good returns in the coming years.

Read more »

Man presses green buy button and red sell button on a graph.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A farmer pats a small beef cattle bovine on the head in a green field with trees in the background.
Broker Notes

Two undervalued agriculture ASX shares to add to your Christmas stocking

These stocks could be a buy before the new year.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »